# PErsonalized Addition of Recombinant LH in Ovarian Stimulation

> **NCT04719000** · PHASE4 · RECRUITING · sponsor: **Fundación Santiago Dexeus Font** · enrollment: 120 (estimated)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** rhFSH+rhLH
- **DRUG:** rhFSH

## Key facts

- **NCT ID:** NCT04719000
- **Lead sponsor:** Fundación Santiago Dexeus Font
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-02-04
- **Primary completion:** 2027-08
- **Final completion:** 2027-11
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-03-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04719000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04719000, "PErsonalized Addition of Recombinant LH in Ovarian Stimulation". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04719000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*